Trial intelligence / Profile preview

UroVaxom for chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)

2007-004609-85Phase 3Completed

Sponsor
OM Pharma
Start
Dec 2007
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in chronic prostatitis (CP) comparing UroVaxom with Placebo (2 arms). Primary endpoint: Responder rate based on NIH-CPSI. Started Dec 2007; status: completed.

02

Drugs

OM-89
03

Conditions

chronic prostatitis (CP)

Beyond the preview

Go deeper on 2007-004609-85.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004609-85.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call